Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sera Prognostics (SERA) Cash & Equivalents (2020 - 2026)

Sera Prognostics filings provide 6 years of Cash & Equivalents readings, the most recent being $3.9 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 2.45% to $3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.9 million, a 2.45% decrease, with the full-year FY2025 number at $3.9 million, down 2.45% from a year prior.
  • Cash & Equivalents hit $3.9 million in Q4 2025 for Sera Prognostics, down from $4.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $90.9 million in Q2 2021 to a low of $2.7 million in Q3 2024.
  • Median Cash & Equivalents over the past 5 years was $9.7 million (2023), compared with a mean of $27.7 million.
  • Biggest five-year swings in Cash & Equivalents: soared 335.47% in 2021 and later crashed 87.01% in 2023.
  • Sera Prognostics' Cash & Equivalents stood at $58.9 million in 2021, then crashed by 49.3% to $29.9 million in 2022, then crashed by 87.01% to $3.9 million in 2023, then rose by 4.2% to $4.0 million in 2024, then fell by 2.45% to $3.9 million in 2025.
  • The last three reported values for Cash & Equivalents were $3.9 million (Q4 2025), $4.1 million (Q3 2025), and $5.0 million (Q2 2025) per Business Quant data.